Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0XQ8A
|
||||
Former ID |
DIB001132
|
||||
Drug Name |
TPN-729
|
||||
Synonyms |
TPN-729B; PDE5 inhibitors (erectile dysfunction/pulmonary arterial hypertension), Shanghai Institute of Materia Medica/Topharman Shanghai
|
||||
Indication | Erectile dysfunction [ICD9: 302.72, 607.84; ICD10:F52.2, N48.4] | Investigative | [543407] | ||
Company |
Shanghai Institute of Materia Medica of the Chinese Academy of Sciences
|
||||
Structure |
Download2D MOL |
||||
Canonical SMILES |
c1(cc(c2c(c1Cl)nc([nH]c2=O)c1c(ccc(c1)S(=O)(=O)N1CCN(CC<br />1)C)OCC)OC)OC
|
||||
Target and Pathway | |||||
Target(s) | CGMP-specific 3',5'-cyclic phosphodiesterase | Target Info | Inhibitor | [543407] | |
KEGG Pathway | Purine metabolism | ||||
cGMP-PKG signaling pathway | |||||
NetPath Pathway | TGF_beta_Receptor Signaling Pathway | ||||
Reactome | cGMP effects | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.